Dermala Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $6.73M
Latest Deal Amount
  • Investors
  • 6

Dermala General Information

Description

Developer of skin products designed to treat prevalent skin diseases. The company's product combines human microbiome science with dermatology and digital health technologies to develop novel consumer products for skin issues as well as offer an application for tracking the treatment outcome and treatment optimization via data analytics, machine learning and artificial intelligence, enabling individuals to get treatment for skin diseases like acne and eczema and skin conditions like skin aging.

Contact Information

Website
www.dermala.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Specialty Retail
Biotechnology
Primary Office
  • JLABS, 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Dermala Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dermala Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 09-Nov-2020 $6.73M 00.000 000.00 Completed Generating Revenue
5. Seed Round 02-May-2018 000000 00.00 00.00 Completed Generating Revenue
4. Accelerator/Incubator 02-Aug-2017 00000 Completed Generating Revenue
3. Seed Round 09-Mar-2017 00000 00000 00000 Completed Generating Revenue
2. Seed Round 22-Jul-2015 $250K $250K 00000 Completed Generating Revenue
1. Accelerator/Incubator 01-Dec-2014 Completed Generating Revenue
To view Dermala’s complete valuation and funding history, request access »

Dermala Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed-2 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed-1 20,210,185 $0.000100 8% $0.01 $0.01 1x $0.01 22.06%
Seed 5,405,405 $0.000100 8% $0.05 $0.05 1x $0.03 9.95%
To view Dermala’s complete cap table history, request access »

Dermala Executive Team (2)

Name Title Board Seat Contact Info
Lada Rasochova Ph.D Co-Founder, President, Chief Executive Officer & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Dermala Board Members (4)

Name Representing Role Since
Asha Nayak Self Board Member 000 0000
Lada Rasochova Ph.D Dermala Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Sara Brand Ph.D True Wealth Ventures Board Member 000 0000
Vlastimil Rasocha Dermala Board Member 000 0000
To view Dermala’s complete board members history, request access »

Dermala Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dermala Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
The Cove Fund Growth/Expansion Minority 000 0000 000000 0
True Wealth Ventures Venture Capital Minority 000 0000 000000 0
San Diego Regional Economic Development Corporation Other 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »